BROADWOOD CAPITAL INC
An institutional investment manager in New York, NY. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1278387.
- Reported value$1.91bn
- Positions6
Holdings: 6 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Monster Beverage Corp NewMNST | COM | 61174X109 | 779 | 40.7% | 8,107,796 | Unchanged | |
| Staar Surgical CoSTAA | COM PAR $0.01 | 852312305 | 463 | 24.2% | 16,123,842 | Unchanged | |
| Axon Enterprise IncAXON | COM | 05464C101 | 389 | 20.3% | 693,504 | Unchanged | |
| Ishares TR | RUSSELL 2000 ETF | 464287655 | 143 | 7.5% | 474,920 | Unchanged | |
| Insight Molecular Dia IncIMDX | COM NEW | 68235C206 | 74.8 | 3.9% | 12,684,884 | Added+753,045 | |
| Lineage Cell Therapeutics inLCTX | COM | 53566P109 | 64.9 | 3.4% | 49,560,992 | Unchanged |
Source: SEC EDGAR, Form 13F-HR, accession 0000919574-26-005163 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.